KalVista Pharmaceuticals, Inc. (KALV)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 511.74M |
| Enterprise Value | 443.60M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.78 |
| Enterprise Value/Revenue | 76.33 |
| Enterprise Value/EBITDA | -3.61 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.91 |
| 52-Week Change 3 | 27.57% |
| S&P500 52-Week Change 3 | 22.38% |
| 52 Week High 3 | 16.88 |
| 52 Week Low 3 | 7.21 |
| 50-Day Moving Average 3 | 12.14 |
| 200-Day Moving Average 3 | 10.99 |
Share Statistics
| Avg Vol (3 month) 3 | 798.9k |
| Avg Vol (10 day) 3 | 348.59k |
| Shares Outstanding 5 | 42.19M |
| Implied Shares Outstanding 6 | 42.29M |
| Float 8 | 24.12M |
| % Held by Insiders 1 | 1.14% |
| % Held by Institutions 1 | 102.59% |
| Shares Short (Apr 15, 2024) 4 | 5.82M |
| Short Ratio (Apr 15, 2024) 4 | 10.49 |
| Short % of Float (Apr 15, 2024) 4 | 14.56% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 13.80% |
| Shares Short (prior month Mar 15, 2024) 4 | 4.92M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Nov 22, 2016 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:14 |
| Last Split Date 3 | Nov 22, 2016 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Apr 30, 2023 |
| Most Recent Quarter (mrq) | Jan 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -42.50% |
| Return on Equity (ttm) | -79.33% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -107.15M |
| Net Income Avi to Common (ttm) | -108.3M |
| Diluted EPS (ttm) | -3.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 75.59M |
| Total Cash Per Share (mrq) | 1.79 |
| Total Debt (mrq) | 7.44M |
| Total Debt/Equity (mrq) | 8.40% |
| Current Ratio (mrq) | 5.44 |
| Book Value Per Share (mrq) | 2.56 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -96.76M |
| Levered Free Cash Flow (ttm) | -56.13M |
© 2024 Yahoo. All rights reserved.